T2 Biosystems (TTOO) develops alternative diagnostic methodologies using its magnetic resonance platform referred to as T2MR.
In this context, its researchers have developed a molecular COVID-19 detection test referred to as the T2SARS-COV-2.
Now, there are a number of biotech companies which have developed antigen testing kits using new technologies in addition to the standard RT-PCR tests available. Recently, serological (antibody) tests have also emerged.
One of the biotechs which I recently covered, Quidel (QDEL) is involved in both PCR and antigen testing.
Given that the number of infection is rising